Eurosurveillance · 2018 · 36 citations · 19 references
Veterinary MedicineImmunologyInfectious DiseasesImmunizationPediatric Infectious DiseasesVaccinologyAdverse Events Following ImmunizationInfant ImmunizationVaccinationVaccine SafetyVaccine Safety SurveillanceVaccine-preventable DiseasesImmunization Safety SurveillancePediatric Vaccine Safety SurveillancePost-marketing SurveillancePost-marketing Surveillance DataPost-marketing Vaccine Safety MonitoringProduct Safety ProfileVaccine Safety In InfantsVaccine Safety Reporting
Background and aim In January 2013, a novel vaccine against Neisseria meningitidis serogroup B, the multicomponent meningococcal serogroup B vaccine (4CMenB), was approved by the European Medicines Agency. We aimed to evaluate the safety profile of this vaccine. Methods: All adverse events following immunisation (AEFI) reported from Germany since the vaccine’s launch in Germany in November 2013 through December 2016 were reviewed and analysed. Results: Through December 2016, a total of 664 individual case safety reports (ICSR) notifying 1,960 AEFI were received. A majority of vaccinees for whom AEFI were reported were children 2 to 11 years of age (n = 280; 42.2%) followed by infants and toddlers aged 28 days to 23 months (n = 170; 25.6%). General disorders and administration site conditions was the System Organ Class (SOC) with the majority of AEFI (n = 977; 49.8%), followed by nervous system disorders (n = 249; 12.7%), and skin and subcutaneous tissue disorders (n = 191; 9.7%). Screening of patient records for immune-mediated and neurological diseases did not raise any safety signal in terms of an increased proportional reporting ratio (PRR). Conclusions: The safety profile described in the Summary of Product Characteristics, in general, is confirmed by data from spontaneous reporting. No safety concerns were identified.
19
Nicoletta Gossger, Matthew D. Snape, Ly‐Mee Yu et al. · JAMA · 2012 · 281 citations
Timo Vesikari, Susanna Esposito, Roman Prymula et al. · The Lancet · 2013 · 274 citations
Lisen Arnheim‐Dahlström, Björn Pasternak, Henrik Svanström et al. · BMJ · 2013 · 273 citations · Full text